Technology
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Bioptimus, a global AI company building the world's first world model for biology, today announced the launch of its Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data generation initiative anchored by a partnership with 10x Genomics, Inc. (Nasdaq: TXG) and Broad Clinical Labs.
About this update from 10x Genomics, Inc.
[{"type":"text","content":"The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world today","length":203,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"The Launch of STELA: Bioptimus is establishing the largest clinically linked multimodal atlas, starting in oncology and immunology tissue, designed to generate harmonized multi-omics patient data.","length":196,"tagName":"p"}]},{"val":[{"type":"text","content":"A Strategic Partnership with 10x Genomics: Leveraging the Xenium spatial transcriptomics platform as the foundational partner for the launch, the initiative sets a new benchmark for reproducible, AI-ready data generation across leading research institutions worldwide.","length":268,"tagName":"p"}]},{"val":[{"type":"text","content":"A Strategic Partnership with the Broad Clinical Labs: A multi-year agreement with Broad Clinical Laboratories to support STELA via the generation of spatial biology data at scale.","length":179,"tagName":"p"}]},{"val":[{"type":"text","content":"Profiling Up to 100,000 Patient Specimens: Representing a ~20-fold increase in scale over existing spatial biology atlases, STELA will integrate spatial technologies, pathology imaging, multi-omics, and longitudinal clinical data across three continents.","length":254,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":897,"olType":false},{"type":"text","content":"PARIS, March 25, 2026 /PRNewswire/ -- Bioptimus, a global AI company building the world's first world model for biology, today announced the launch of its Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data generation initiative anchored by a partnership with 10x Genomics, Inc. (Nasdaq: TXG) and Broad Clinical Labs.","length":347,"tagName":"p"},{"type":"image","alt":"Bioptimus logo (PRNewsfoto/Bioptimus)","displaySize":"","headline":null,"caption":"Bioptimus logo (PRNewsfoto/Bioptimus)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":150,"url":"https://media.zenfs.com/en/prnewswire.com/21d594420a53683d175d3c757384bfcc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FJ6w_tdqDmFr4KtkJaQZtA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI2NA--/https://media.zenfs.com/en/prnewswir...